Neuralgia nerwu trójdzielnego
Epidemiologia

Neuralgia nerwu trójdzielnego (TN) to rzadka, ale istotna klinicznie jednostka chorobowa, charakteryzująca się ostrym, napadowym, jednostronnym bólem twarzy o charakterze porażenia prądem elektrycznym, lokalizowanym w obszarze unerwienia nerwu trójdzielnego. Zapadalność globalna waha się od 4 do 29 przypadków na 100 000 osobolat, z wyjątkiem Korei, gdzie odnotowano 100,21/100 000 osobolat w 2018 r. Średni wiek zachorowania to 53-57 lat, z wyższą częstością u osób powyżej 60 lat. Kobiety stanowią około 60% chorych, a ból częściej dotyczy prawej strony twarzy (stosunek 1,5:1). Neuralgia nerwu trójdzielnego współwystępuje ze stwardnieniem rozsianym (SM) u 1-6,3% pacjentów, z 20-krotnie wyższym ryzykiem rozwoju TN u chorych na SM. Czynniki ryzyka obejmują nadciśnienie tętnicze i migreny, a TN wiąże się ze zwiększonym ryzykiem udaru niedokrwiennego oraz zaburzeniami psychicznymi, w tym lękiem i depresją, co podkreśla konieczność kompleksowej oceny pacjentów. Koszty leczenia rosną, np. w Korei wzrosły o 159,77% w latach 2014-2018, a w USA TN jest częstą przyczyną wizyt na oddziałach ratunkowych, głównie u kobiet (71,4%) w średnim wieku 61,6 lat.

Epidemiologia neuralgii nerwu trójdzielnego

Neuralgia nerwu trójdzielnego (TN) jest rzadkim schorzeniem charakteryzującym się ostrym, napadowym, jednostronnym bólem twarzy o charakterze porażenia prądem elektrycznym, występującym w obszarze unerwienia nerwu trójdzielnego. Mimo rzadkiego występowania, choroba ta znacząco wpływa na jakość życia pacjentów, powodując duże obciążenie fizyczne i psychiczne.123

Częstotliwość występowania i zapadalność

Dane epidemiologiczne dotyczące neuralgii nerwu trójdzielnego są zróżnicowane. Globalna zapadalność na TN waha się od 4 do 29 przypadków na 100 000 osobolat, w zależności od badań populacyjnych przeprowadzonych w USA i Wielkiej Brytanii.45 W Stanach Zjednoczonych szacuje się, że rocznie diagnozuje się od 12 000 do 87 000 nowych przypadków.4 Natomiast w Wielkiej Brytanii roczna zapadalność szacowana jest na 8 przypadków na 10 000 osób.67

Interesujące dane pochodzą z Korei, gdzie w badaniu populacyjnym przeprowadzonym w latach 2014-2018 stwierdzono zapadalność na poziomie 100,21 przypadków na 100 000 osobolat w 2018 roku, co jest znacznie wyższą wartością niż w innych krajach.82

Chorobowość (występowanie) neuralgii nerwu trójdzielnego w badaniach populacyjnych szacuje się na poziomie 0,03% do 0,3%, co plasuje ją w podobnym zakresie co stwardnienie rozsiane i chorobę Parkinsona.159

Rozkład demograficzny

Wiek: Neuralgia nerwu trójdzielnego najczęściej występuje u osób po 50. roku życia, a średni wiek zachorowania wynosi między 53 a 57 lat.41 Zapadalność wzrasta wraz z wiekiem, osiągając wartość 17,5 przypadków na 100 000 osobolat w grupie wiekowej 60-69 lat oraz 25,6 przypadków wśród osób powyżej 70. roku życia.1011 W badaniu koreańskim najwyższą częstość występowania TN zaobserwowano w grupie wiekowej 51-59 lat.8

Schorzenie to rzadko jest diagnozowane w dzieciństwie i u osób przed 40. rokiem życia.1 Pacjenci z neuralgią nerwu trójdzielnego, u których objawy pojawiają się między 20. a 40. rokiem życia, częściej cierpią na demielinizacyjne zmiany w moście spowodowane stwardnieniem rozsianym, a ich neuralgia ma zwykle charakter objawowy lub wtórny.412

Płeć: Neuralgia nerwu trójdzielnego występuje częściej u kobiet niż u mężczyzn. Stosunek zachorowań kobiet do mężczyzn waha się od 1,5:1 do 3:2, w zależności od badania.14 W badaniu koreańskim stosunek ten wynosił 1:2,14 na korzyść kobiet.8 Ogólnie przyjmuje się, że około 60% pacjentów z TN stanowią kobiety.10

Rozkład geograficzny i etniczny

Nie zidentyfikowano wyraźnych różnic etnicznych czy geograficznych w zapadalności na neuralgię nerwu trójdzielnego.10 Jednak w badaniu koreańskim zauważono, że TN częściej występowała w obszarach metropolitalnych, takich jak Seul i Gyeonggi.13

Interesujące obserwacje dotyczą strony twarzy dotkniętej neuralgią – badania wskazują, że prawa strona twarzy jest częściej dotknięta niż lewa (w stosunku 1,5:1), a około 3% przypadków ma charakter obustronny.1415 W badaniu obejmującym 508 pacjentów z jednostronną neuralgią nerwu trójdzielnego, ból był zlokalizowany po lewej stronie u 38% pacjentów.16

Neuralgia nerwu trójdzielnego a stwardnienie rozsiane

Występowanie neuralgii nerwu trójdzielnego u pacjentów ze stwardnieniem rozsianym (SM) wynosi między 1% a 6,3%.1 Według niektórych źródeł, około 1% pacjentów z SM rozwija neuralgię nerwu trójdzielnego, natomiast 2% pacjentów z TN ma stwardnienie rozsiane.4

Pacjenci cierpiący na obie choroby często mają obustronną neuralgię nerwu trójdzielnego.4 Wiek zachorowania na TN u pacjentów z SM jest niższy niż w przypadku klasycznej neuralgii, a ryzyko rozwoju TN u pacjentów z SM jest 20-krotnie wyższe niż w populacji ogólnej.17

Badania sugerują, że między 4 a 6 osób na 100 z SM doświadcza neuralgii nerwu trójdzielnego, co jest około 400 razy częstsze niż w populacji ogólnej.18 Neuralgia nerwu trójdzielnego może być wczesnym objawem SM, ale jej prawdopodobieństwo wzrasta wraz z czasem trwania SM.18

Czynniki ryzyka i choroby współistniejące

Pacjenci z nadciśnieniem tętniczym mają nieco wyższą zapadalność na neuralgię nerwu trójdzielnego niż osoby z prawidłowym ciśnieniem.1 Nadciśnienie i migreny mogą być czynnikami ryzyka rozwoju TN.19

W duńskim badaniu analizującym trajektorie chorób na podstawie danych od 7,2 miliona osób w latach 1994-2018, zidentyfikowano 27 chorób czasowo związanych z diagnozą neuralgii nerwu trójdzielnego.20 Stwierdzono, że sama neuralgia nerwu trójdzielnego i jej leczenie pierwszego rzutu wiązały się ze zwiększonym ryzykiem udaru niedokrwiennego, co sugeruje, że czynniki ryzyka naczyniowego powinny być rutynowo oceniane u osób z TN.20

Zaburzenia psychiczne są częstsze u pacjentów z neuralgią nerwu trójdzielnego. W badaniach epidemiologicznych wykazano zwiększony poziom lęku i depresji z podwyższonym ryzykiem samobójstwa.21 Częstość występowania zaburzeń depresyjnych, lękowych i zaburzeń snu jest znacznie wyższa u pacjentów z TN niż w grupie kontrolnej.2223

Obciążenie ekonomiczne i wykorzystanie zasobów opieki zdrowotnej

Neuralgia nerwu trójdzielnego generuje znaczne koszty opieki zdrowotnej. W Korei koszty medyczne związane z leczeniem TN wzrosły gwałtownie z 3 910 766 USD pod koniec 2014 roku do 6 248 592 USD w 2018 roku, co stanowi wzrost o 159,77%.13

W Stanach Zjednoczonych neuralgia nerwu trójdzielnego nie jest rzadką przyczyną wizyt na oddziałach ratunkowych. W badaniu wykazano, że w okresie badawczym łącznie 132 824 wizyty na oddziałach ratunkowych były związane z neuralgią nerwu trójdzielnego. Średni wiek pacjentów wynosił 61,6 lat, a kobiety stanowiły 71,4% wszystkich wizyt.24

Porównanie zapadalności na neuralgię nerwu trójdzielnego w różnych krajach
Kraj/Region Zapadalność (na 100 000 osobolat) Stosunek kobiet do mężczyzn Najczęstszy wiek zachorowania
USA i Wielka Brytania 4-29 3:2 53-57 lat
Korea 100,21 1:2,14 51-59 lat
Holandia 12,6 Brak danych Brak danych
Rochester, Minnesota (USA) 4,3 Brak danych Brak danych
Wielka Brytania (badanie praktyki ogólnej) 8 na 10 000 Brak danych Brak danych

Wyzwania diagnostyczne i opóźnienie w diagnozie

Jednym z głównych wyzwań związanych z neuralgią nerwu trójdzielnego jest opóźnienie w diagnozie. Według niektórych badań, średni czas do postawienia diagnozy wynosi 7 lat.25 Problem ten podkreśla znaczenie zwiększania świadomości na temat choroby wśród lekarzy i tworzenia specjalistycznych ośrodków leczenia TN.

Rzeczywista chorobowość neuralgii nerwu trójdzielnego może być wyższa niż szacowana, ze względu na częste przypadki błędnych diagnoz.26 Dane z firmy Datamonitor sugerują, że w 2011 roku w siedmiu głównych rynkach (USA, Japonia, Francja, Niemcy, Włochy, Hiszpania i Wielka Brytania) było około 822 200 przypadków TN, co wskazuje, że choroba stanowi większe obciążenie niż wcześniej sądzono.27

Przypadki rodzinne i genetyka

Większość przypadków neuralgii nerwu trójdzielnego ma charakter sporadyczny, bez wyraźnych czynników ryzyka. Jednak odnotowano rzadkie przypadki rodzinnego występowania TN, co doprowadziło do badań nad możliwą genetyczną i molekularną podstawą patofizjologii tej choroby.28

Przypadki rodzinne stanowią 1-2% pacjentów. Badania nad takimi przypadkami wskazują na autosomalny dominujący wzór dziedziczenia z fenomenem antycypacji genetycznej.10 Mimo tych obserwacji, genetyczne podłoże neuralgii nerwu trójdzielnego nie jest jeszcze dobrze poznane.29

Nadzór nad neuralgią nerwu trójdzielnego

Z uwagi na rzadkie występowanie neuralgii nerwu trójdzielnego, dane dotyczące nadzoru epidemiologicznego są ograniczone. Jednak coraz więcej badań próbuje usystematyzować podejście do monitorowania tej choroby.

Badania obserwacyjne i rejestry

Prowadzone są różne badania epidemiologiczne mające na celu lepsze zrozumienie rozkładu i charakterystyki neuralgii nerwu trójdzielnego. Przykładem jest projekt TNEPIX (Trigeminal Neuralgia epidemiology and informatics for characterising disease occurrence), który ma dostarczyć dowodów w trzech obszarach: (a) szacunki epidemiologiczne i geograficzne, (b) ścieżki pacjentów od objawów przez diagnozę do wyników leczenia oraz (c) możliwości wczesnej diagnostyki i terapii opracowane przy użyciu uczenia maszynowego.25

Firmy badawcze, takie jak IMARC Group, prowadzą kompleksowe analizy rynku neuralgii nerwu trójdzielnego, obejmujące ocenę trendów epidemiologicznych, wielkości populacji pacjentów i prognozy do 2034 roku w siedmiu głównych rynkach.3031

Standardy diagnostyczne i klasyfikacje

Istotnym elementem nadzoru epidemiologicznego jest stosowanie standardowej nomenklatury i kryteriów diagnostycznych w celu dokładnego ustalenia rzeczywistej chorobowości i zapadalności. Międzynarodowa klasyfikacja bólów głowy (ICHD) zapewnia ramy dla takiej standaryzacji.9

Ważne jest również rozróżnienie między różnymi typami neuralgii nerwu trójdzielnego. Około 85% przypadków TN to typ klasyczny, znany jako klasyczna neuralgia nerwu trójdzielnego (CTN), podczas gdy pozostałe przypadki to neuralgia wtórna (STN).6 Uważa się, że STN jest inicjowana przez stwardnienie rozsiane lub zmiany zajmujące przestrzeń, które wpływają na nerw trójdzielny, natomiast główną przyczyną CTN jest ucisk nerwu trójdzielnego w regionie strefy wejścia korzenia grzbietowego przez naczynie krwionośne.6

Leczenie neuralgii nerwu trójdzielnego powinno odbywać się w środowisku multidyscyplinarnym, co pozwala pacjentom na wybór najlepszej dla nich opcji.6 Pomimo licznych badań nad TN, nadal brakuje metody leczenia o 100% skuteczności.32 Pierwszą linią leczenia jest farmakoterapia, jednak w przypadku utrzymywania się objawów może być konieczne leczenie chirurgiczne.32 Szacuje się, że nawet 50% pacjentów z TN będzie potrzebowało jakiejś formy operacji wcześniej czy później.33

Wpływ na jakość życia i obciążenie chorobą

Neuralgia nerwu trójdzielnego znacząco wpływa na jakość życia pacjentów. Intensywność i nieprzewidywalność bólu może być fizycznie i psychicznie obezwładniająca, powodując poważne obciążenie chorobą (BOI) i upośledzenie jakości życia pacjenta (QoL).3

Badanie przekrojowe przeprowadzone w specjalistycznym ośrodku leczenia bólu twarzy wykazało, że mimo poprawy zgłaszanej przez 79% pacjentów od rozpoczęcia leczenia, większość z nich nadal przyjmowała leki, przy czym 42% stosowało politerapię.34 Wysoka liczba obecnych lub wcześniejszych leków, utrzymujący się ból lub powikłania pomimo interwencji chirurgicznych i/lub medycznych oraz obniżona jakość życia u osób z obecnym zaburzeniem bólowym podkreślają obciążenie związane z TN i pozostające niezaspokojone potrzeby medyczne.34

Z powodu charakteru i intensywności bólu, TN ma znaczący wpływ na jakość życia pacjentów. Osoby dotknięte tą chorobą cierpią z powodu opóźnienia diagnozy, strachu przed nagłym wystąpieniem ataku, działań niepożądanych leczenia i braku wsparcia psychologicznego.10 Częstość występowania lęku i depresji wśród pacjentów z TN jest prawie 3 razy wyższa niż w populacji ogólnej, co wynika z intensywności bólu i długiego czasu trwania choroby.10

TN może również powodować gorsze wyniki w codziennych czynnościach, izolację społeczną, zaburzenia snu, zmęczenie i anoreksję.10 W świetle powyższego, ważne jest, aby postępowanie z tymi pacjentami miało charakter multidyscyplinarny, angażujący specjalistów w dziedzinie zdrowia psychicznego.10

TN może mieć również znaczący wpływ ekonomiczny, ponieważ początek choroby przypada zwykle na wiek produkcyjny, a ponad połowa pacjentów ma trudności z wykonywaniem obowiązków zawodowych.10

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 14.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Trigeminal Neuralgia – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK554486/
    Trigeminal neuralgia affects 4 to 13 per 100,000 people annually. Women are more commonly affected than men. The female-to-male prevalence ratio ranges from 1.5 to 1.7 to 1. Most cases of trigeminal neuralgia occur after age 50, but the disease may be seen in the second and third decades of life; trigeminal neuralgia is rarely diagnosed in childhood. The lifetime prevalence of trigeminal neuralgia in population-based studies is estimated at 0.16% to 0.3%. […] The prevalence of trigeminal neuralgia in patients with multiple sclerosis is between 1% and 6.3%. Patients with hypertension have a slightly higher incidence of trigeminal neuralgia than normotensive persons.
  • #2 Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea
    https://pmc.ncbi.nlm.nih.gov/articles/PMC8255158/
    Trigeminal neuralgia (TN) is one of the most painful disorder in the orofacial region, and many patients have suffered from this disease. […] Thus, this study was performed to clarify the epidemiological characteristics of TN in the Korean population. This is the first national study to investigate the prevalence of TN in Korean patients. […] The incidence of TN was 100.21 per 100,000 person-years in the year of 2018 in Korea, and the male to female ratio was 12.14. The age group of 51-59 years had the highest prevalence of TN. […] The results in this study will not only help to study the characteristics of TN, but also serve as an important basis for the effective management of TN in Korea. […] In the present study, the prevalence of TN was 100.25 per 100,000 person-years in 2018, with the highest prevalence rate in both sexes in the age group of 51-59 years.
  • #3 Burden of illness of trigeminal neuralgia among patients managed in a specialist center in England | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-01198-z
    Trigeminal neuralgia (TN) is a rare condition that affects the trigeminal nerve, resulting in extreme, sporadic, sudden, electric shock-like unilateral facial pain. The condition occurs most frequently in people over 50 years of age, and is more prevalent in women than in men. The intensity and unpredictability of the pain can be physically and mentally incapacitating, and result in a severe burden of illness (BOI) and impaired patient quality of life (QoL). […] The current study is a cross-sectional component of a longitudinal survey project, and consists of assessments performed at a single timepoint, in a cohort of patients receiving a high level of clinical care at a specialist facility which has been managing TN patients over several years using a multidisciplinary care pathway. […] This cross-sectional study, conducted at a specialist facial pain treatment facility, consisted of a subpopulation of patients of an earlier study. The study yielded several key findings. Overall, the results indicate that a multidisciplinary care pathway can produce substantial benefit in a majority of patients, as evidenced by 79% of patients reporting improvement in the PGIC measure since beginning of treatment at this clinic.
  • #4 Trigeminal Neuralgia: Practice Essentials, Background, Anatomy
    https://emedicine.medscape.com/article/794402-overview
    Trigeminal neuralgia has an incidence of 4 to 29 cases per 100,000 person-years, according to population studies in the US and UK. This corresponds to approximately 12,000 to 87,000 new cases diagnosed annually in the US. The condition is more common in females, with a female-to-male ratio of 3:2, and its prevalence increases with age, with a mean onset between 53 and 57 years. Patients who present with the disease when aged 20-40 years are more likely to suffer from a demyelinating lesion in the pons secondary to multiple sclerosis; younger patients also tend to have symptomatic or secondary trigeminal neuralgia. There have also been occasional reports of pediatric cases of trigeminal neuralgia. The estimated lifetime prevalence ranges from 0.16% to 0.3%. Approximately 1% of patients with multiple sclerosis develop trigeminal neuralgia, whereas 2% of patients with trigeminal neuralgia have multiple sclerosis. Patients with both conditions often have bilateral trigeminal neuralgia.
  • #5 Trigeminal neuralgia | MedLink Neurology
    https://www.medlink.com/articles/trigeminal-neuralgia
    Trigeminal neuralgia is a rare condition. The prevalence is estimated to be 0.03% to 0.3%, similar to multiple sclerosis and Parkinson disease. Incidence is estimated to be 4.3 to 8 per 100,000. One observational study in central Sweden reported an incidence of 5.5 cases per 100,000 person-years. It is more prevalent in women and in people over 60 years of age. Epidemiological studies suggest incidence increases with age, from 16.3 for patients in their 40s compared to 30.6 for patients older than 80 years. […] The etiology of classical trigeminal neuralgia is attributed to demyelination of the trigeminal afferent pathway in the dorsal root entry zone, which is thought to lead to discharges of the nerve spontaneously or in response to a normally innocuous afferent stimulus. Neurovascular compression, typically by a redundant or tortuous loop of the superior cerebellar artery, is thought to cause that demyelination. A space-occupying lesion can compress the trigeminal nerve root and produce similar symptomatology. MRI may reveal neurovascular contact of the trigeminal nerve root, but this can also be seen in asymptomatic patients, so it is not diagnostic. To convincingly be diagnosed with classical trigeminal neuralgia, there should be evidence of nerve atrophy or displacement, which has a specificity of 97% (100% if at the root entry zone). It is important to note that the presence of nerve compression does not mean trigeminal neuralgia symptoms will occur, as one study found that 92 of 100 asymptomatic cases reviewed were found to have a vessel compressing the trigeminal nerve. A 2024 meta-analysis of 13 observational studies across 1770 nerves (728 symptomatic and 1042 asymptomatic) found a significant difference between the symptomatic and asymptomatic trigeminal nerves, with 53.2% having morphological changes like atrophy, dislocation, distortion, flattening, or indentation compared to 7.9% on the asymptomatic side. Demyelination due to multiple sclerosis can lead to trigeminal neuralgia symptoms, and trigeminal neuralgia has a higher incidence in patients with multiple sclerosis. […]
  • #6 Trigeminal Neuralgia | SpringerLink
    https://link.springer.com/chapter/10.1007/978-981-15-1346-6_26
    85% of cases of Trigeminal Neuralgia are of the classic type known as Classical Trigeminal Neuralgia (CTN), while the remaining cases can be separated to secondary Trigeminal Neuralgia (STN). […] STN is thought to be initiated by multiple sclerosis or a space-occupying lesion affecting the trigeminal nerve, whereas the leading cause of CTN is known to be compression of the trigeminal nerve in the region of the dorsal root entry zone by a blood vessel. […] The management of TN patients should be carried out in a multidisciplinary setting to allow the patients to choose the best-suited option for them. […] A systematic review highlighted that the range of TN prevalence was 0.030.3%, mostly women were affected, and the affected age range was 3767 years old. […] NICE guideline data and studies indicate that a survey carried out within general practice in the United Kingdom, which highlighted that the annual incidence of trigeminal neuralgia was 8 per 10,000. […] The true prevalence of this condition remains unclear as there is little data to support the evidence of how common this condition is.
  • #7 Pulsenotes | Trigeminal neuralgia notes
    https://app.pulsenotes.com/medicine/neurology/notes/trigeminal-neuralgia
    Trigeminal neuralgia is a rare condition that is more common in women. […] The exact incidence of trigeminal is unclear. Annual incidence in the UK is estimated to be 8 per 10,000 although due to its rarity these estimations can vary wildly. It is around twice as common in women compared to men.
  • #8 Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea
    https://www.epain.org/journal/view.html?volume=34&number=3&spage=332
    Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea […] Background: Trigeminal neuralgia (TN) is one of the most painful disorder in the orofacial region, and many patients have suffered from this disease. For the effective management of TN, fundamental epidemiologic data related to the target population group are essential. Thus, this study was performed to clarify the epidemiological characteristics of TN in the Korean population. This is the first national study to investigate the prevalence of TN in Korean patients. […] Methods: From 2014 to 2018, population-based medical data for 51,276,314 subscribers to the National Health Insurance Service of Korea were used for this study. […] Results: The incidence of TN was 100.21 per 100,000 person-years in the year of 2018 in Korea, and the male to female ratio was 1:2.14. The age group of 51-59 years had the highest prevalence of TN. Constant increases in medical cost, regional imbalance, and differences in prescription patterns by the medical specialties were showed in the management of TN.
  • #9 Epidemiology | SpringerLink
    https://link.springer.com/chapter/10.1007/978-3-030-60687-9_3
    Trigeminal Neuralgia is considered a rare facial pain syndrome with prevalence rates ranging between 0.03% and 0.3%. It is more commonly seen in females during their fourth, fifth, or sixth decades of life. […] It is important to use standard nomenclature and diagnostic criterias to accurately ascertain true prevalence and incidence rates of a disease; International classification of headache disorder (ICHD) provides a framework for the same. […] Prevalence of trigeminal neuralgia: a systematic review. 2016. […] Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984.
  • #10 Diagnosis and treatment of trigeminal neuralgia: Consensus statement from the Spanish Society of Neurology’s Headache Study Group | Neurología (English Edition)
    https://www.elsevier.es/es-revista-neurologia-english-edition–495-articulo-diagnosis-treatment-trigeminal-neuralgia-consensus-S2173580823000275
    Epidemiological studies are scarce, and generally include small samples. The prevalence of TN is estimated at 0.3%, with an incidence rate of 12.6 cases/100 000 person-years. Incidence increases with age, with rates of 17.5 cases/100 000 person-years in the population aged 60-69 years and 25.6 cases among those aged 70 years and older. Mean age of onset is 53.9 years; women are more frequently affected (60%). No ethnic or geographical differences in incidence have been identified, although some diseases, such as multiple sclerosis (MS), do appear to increase the risk of TN. Familial cases are rare, accounting for 1%-2% of patients. Studies of familial cases report an autosomal dominant inheritance pattern with a genetic anticipation phenomenon. Due to the nature and the intensity of the pain, TN has a considerable impact on patients’ quality of life. These patients suffer as a result of diagnostic delay, fear of sudden onset of an attack, adverse reactions to treatment, and a lack of psychological support. The incidence of anxiety and depression among patients with TN is nearly 3 times higher than in the general population, as a result of the intensity of pain and long duration of the disease. The disease may also cause poor performance in activities of daily living, social isolation, sleep alterations, fatigue, and anorexia. In the light of all of the above, it is important for the management of these patients to take a multidisciplinary approach involving mental health professionals. TN can also have a considerable economic impact, as disease onset is usually during working age, and more than half of patients present difficulties performing work duties.
  • #11 Microsurgical treatment of trigeminal neuralgia in patients older than 70 years: An efficacy and safety study | Neurología (English Edition)
    https://www.elsevier.es/en-revista-neurologia-english-edition–495-articulo-microsurgical-treatment-trigeminal-neuralgia-in-S2173580817301013
    Trigeminal neuralgia (TN) is a unilateral disorder characterised by paroxysmal, electric shock-like pain of abrupt termination limited to the territory of one or more branches of the trigeminal nerve. It is a rare condition, with an estimated annual incidence of 4.3-4.7 cases per 100000 population. It typically appears in adults older than 50. Its incidence has been found to increase with age up to rates of 17.5 and 25.6 cases per 100000 population in patients older than 60 and 70 years, respectively. […] Numerous studies have addressed immediate and long-term outcomes of MVD in series of patients followed up for a mean of over 5 years; these studies report initial success rates ranging between 76% and 99%, long-term success rates of 62% to 89%, and relapse rates of 4% to 38%. […] There is growing interest in MVD for elderly patients. This may be explained by population ageing and the increasing number of people who maintain a good health status until the last decades of life and wish to preserve their quality of life. Prevalence of TN starts to increase at the age of 60. If left untreated, this condition may significantly damage patients health. MVD has been shown to be superior to radiosurgery and percutaneous ablation techniques in terms of initial and long-term effectiveness; this superiority has been analysed in elderly patients setting the cut-off age at 65 or 70. […] As a general rule, success rates and pain-free survival times in elderly patients are similar to those seen in younger patients. In some series, elderly patients have achieved higher rates of complete pain resolution than younger patients.
  • #12 Trigeminal neuralgia: MedlinePlus Medical EncyclopediaLock
    https://medlineplus.gov/ency/article/000742.htm
    Trigeminal neuralgia (TN) is a nerve disorder. It usually affects adults above age 50 years, but it can occur at any age. Women are affected more often than men. […] When TN affects people younger than 40, it is often due to MS or a tumor.
  • #13 Epidemiology of trigeminal neuralgia: an electronic population health data study in Korea
    https://www.epain.org/journal/view.html?volume=34&number=3&spage=332
    Conclusions: The results in this study will not only help to study the characteristics of TN, but also serve as an important basis for the effective management of TN in Korea. […] In Korea, one study previously mentioned that the prevalence of TN was 81.8 per 100,000 person-years. However, there was no consideration of the various epidemiological characteristics of TN in that study. In the present study, we used the most up-to-date data available data between 2014 and 2018 in Korea, with other various parameters such as regional distribution, medical cost, healthcare resource utilization, and prescription patterns by medical specialty. In view of the regional distribution, TN was more prevalent in the metropolitan areas, such as Seoul and Gyeonggi. […] The medical cost for the treatment of TN in Korea has increased rapidly from 3,910,766 USD at the end of 2014 to 6,248,592 USD in 2018, with an increase of 159.77%.
  • #14 Trigeminal neuralgia | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/trigeminal-neuralgia?embed_domain=external.radpair.comradiopaedia-icon-144.pngfavicon.ico&lang=us
    The incidence of trigeminal neuralgia is approximately 4.3 per 100,000 per annum. The vast majority of cases are unilateral, with the right side of the face being affected more commonly (1.5:1); around 3% are bilateral. It peaks around age 60 to 70 years, and its prevalence increases with age 1,4. […] Multiple sclerosis may also cause trigeminal neuralgia and, indeed, its incidence is much higher in multiple sclerosis patients than in the general population. It is thought that both pontine plaques and neurovascular compression in combination produce a „double-crush” mechanism whereby intra-pontine inflammatory demyelination and cisternal mechanical demyelination affect the same first-order neurons 20. Of interest, high T2/FLAIR signal of the intrapontine segment of the trigeminal nerve is encountered in approximately 5% of cases, often symetrically 23. The etiology of this is unclear as is whether this finding increases the likelihood of trigeminal neuralgia 23.
  • #15
    https://journals.lww.com/njms/fulltext/2019/10020/prevalence_of_trigeminal_neuralgia_in_indian.12.aspx
    The right side of the face is more involved than the left side, and it is more commonly found in rural population than urban population. […] TN is a rare nerve disorder having limited statistical data. […] Our study has been conducted on a large sample size and successful in establishing the prevalence and incidence of TN i.e it is more common in females than males, the right side of the face is more involved than the left side, and it is more commonly found in rural population than urban population.
  • #16 Side of facial pain in trigeminal neuralgia in: Journal of Neurosurgery Volume 40 Issue 4 (1974) Journals
    https://thejns.org/view/journals/j-neurosurg/40/4/article-p514.xml
    The side of facial pain was studied in 508 patients with unilateral trigeminal neuralgia. The pain was left-sided in 38%. There was no association between the side of facial pain and handedness, or in a smaller group between the side of facial pain and an elevated ipsilateral petrous apex. The apparent right-sided predominance of trigeminal neuralgia remains unexplained.
  • #17 Trigeminal neuralgia | MedLink Neurology
    https://www.medlink.com/articles/trigeminal-neuralgia
    In cases of trigeminal neuralgia caused by multiple sclerosis, the age of onset is younger than classical trigeminal neuralgia, and patients with multiple sclerosis have a 20-fold increased risk of developing trigeminal neuralgia than the general population. Whereas idiopathic or neurovascular trigeminal neuralgia is almost always (97%) unilateral, when trigeminal neuralgia occurs in multiple sclerosis, it may be bilateral in up to 30% of patients. The mechanism of injury in this population is a proposed double crush phenomenon, with the formation of a pontine plaque and neurovascular compression both playing a role. Trigeminal neuralgia secondary to multiple sclerosis is more prominent in females than males; one metaanalysis found a prevalence of 2.4% in males to 3.8% in females.
  • #18 Trigeminal neuralgia | MS Trust
    https://mstrust.org.uk/a-z/trigeminal-neuralgia
    Recent research suggests that between four and six in every 100 people with MS experience trigeminal neuralgia which is about 400 times more often than the general population. […] Trigeminal neuralgia is sometimes an early symptom in MS, but it also becomes more likely the longer you have had MS. […] It is rare for people under 40 who do not have MS to experience trigeminal neuralgia so, for those in this age range, it is particularly important to consider if the symptom is part of their MS.
  • #19 Trigeminal Neuralgia | PM&R KnowledgeNow
    https://now.aapmr.org/trigeminal-neuralgia/
    TN is a rare disease. Epidemiological studies showed that approximately 4 to 28.9/100,000 persons worldwide experience TN. In the United States, there are approximately 15,000 new cases each year. Classic TN accounts for about 80% of cases, secondary TN 15% and idiopathic TN 5%. Females are 1.5 times more likely to have trigeminal neuralgia. The disease can appear at any age however it is rare in children, and it occurs after age 40 in more than 90% of cases. Peak age of disease onset is between 52-58 years old for classical type TN and 30-35 years for the secondary form of TN. Familial cases, though rare, have also been reported. Hypertension and migraines may be risk factors for developing TN. No methods for primary prevention have been proposed.
  • #20 Trigeminal neuralgia and its comorbidities: a nationwide disease trajectory study.
    https://vbn.aau.dk/en/publications/trigeminal-neuralgia-and-its-comorbidities-a-nationwide-disease-t
    There is a limited understanding of risk factors and comorbidities in trigeminal neuralgia, a disease characterized by paroxysms of severe unilateral facial pain and a higher incidence in women. […] We aim to identify temporally associated comorbidities involving trigeminal neuralgia by analyzing nationwide disease trajectories. […] Using data from 7.2 million unique individuals in the Danish National Patient Register between 1994 and 2018, each individual diagnosed with trigeminal neuralgia was compared with 10,000 matched controls to identify co-occurring diseases. […] In the Danish population, a trigeminal neuralgia diagnosis is temporally associated with 27 diseases revealed in systematic disease trajectories. […] Trigeminal neuralgia itself and its first-line treatment, but not a stroke polygenic risk score, was associated with an increased risk of ischemic stroke indicating that vascular risk factors should be routinely assessed in individuals with trigeminal neuralgia.
  • #21 Trigeminal neuralgia: a practical guide | Practical Neurology
    https://pn.bmj.com/content/21/5/392
    Trigeminal neuralgia (TN) is characterised by recurrent, unilateral, brief (1s2min), very painful, electric shock-like pain episodes in the trigeminal distribution that are abrupt in onset and termination. […] Epidemiological studies show increased anxiety and depression, with increased risk of suicide. This highlights the importance of prompt diagnosis, investigations and treatment. […] The lifetime prevalence of TN is estimated to be 0.16%0.3%, while the annual incidence is 429 per 100000 person-years. It is more prevalent in women than in men (F:M ratio 3:2). The incidence increases with age, with a mean age of onset of 5357 years and range of 2493 years in adult series. Furthermore, a recent paediatric headache clinic of 1040 identified five children in the age range 9.516.5 years with TN.
  • #22 Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-015-0548-y
    Trigeminal neuralgia (TN) is a common cause of chronic orofacial pain. The annual incidence of TN is 4 to 13 per 100,000 people. Women are more often affected than men, with an approximate male to female ratio of 1:1.7. To date, national data and large-scale studies regarding the association between TN and risk of subsequent psychiatric disorders are lacking. Our nationwide population-based retrospective cohort study provides further evidence of an excessive risk of depressive, anxiety, and sleep disorders among patients with TN. Depressive, anxiety, and sleep disorders are treatable psychiatric illnesses and have great impact on the quality of life for patients with TN. Therefore, clinicians should be alerted to the possibility of patients with TN developing depressive, anxiety, or sleep disorders.
  • #23 Risk of psychiatric disorders following trigeminal neuralgia: a nationwide population-based retrospective cohort study | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-015-0548-y
    The adjusted hazard ratio (aHR) of depressive disorder, anxiety disorder and sleep disorder in subjects with TN was higher than that of the controls during the follow-up. […] A higher prevalence of psychiatric co-morbidities, especially depressive disorder, has been proven in patients with TN; however, a clear temporal-causal relationship between TN and specific psychiatric disorders has not been well established. […] Our study sample comprised 3273 patients with TN and 13,092 control patients without TN. During the follow-up period, 176 (5.4 %) patients with TN and 267 (2.0 %) comparison patients were diagnosed with psychiatric illnesses. Overall, significantly higher incidences of depressive disorder, anxiety disorder, and sleep disorder were observed in the patients with TN than in the comparison patients.
  • #24
    https://journals.lww.com/ccmjournal/abstract/2013/12001/433__epidemiology_of_hospital_based_emergency.395.aspx
    Trigeminal neuralgia (TN) is a frequent cause of paroxysmal severe facial pain and headache in adults. The incidence of TN is thought to increase with age, with an annual incidence of 4 to 13 per 100,000 people in prior studies. […] During the study period, a total of 132,824 ED visits presented with trigeminal neuralgia. The mean age of these ED visits was 61.6 years. Females comprised 71.4% of all ED visits. Medicare was the major payer covering 52.4% of all ED visits. […] Trigeminal neuralgia is not an infrequent cause of emergency department visits in United States. Females and those in the 6th decade of life constitute the majority of visits. Hospital resource utilization is significant.
  • #25 TNEPIX: Trigeminal Neuralgia epidemiology and informatics for characterising disease occurrence, patient journeys, healthcare impact and early diagnostic indications as an evidence package for establishment of UK specialist care centres | CPRD
    https://www.cprd.com/approved-studies/tnepix-trigeminal-neuralgia-epidemiology-and-informatics-characterising-disease
    Trigeminal Neuralgia (TN) is a rare facial pain condition. Prevalence estimates range from 0.1 to 0.2 per thousand patients. […] However, current average time to diagnosis is 7 years. […] Establishing more specialist care centres requires empirical evidence of distribution and patient diagnostic journey for TN in the UK. […] This study sets out to provide the required evidence in three areas: (a) epidemiological and geographical estimates, (b) patient journeys from symptoms through to diagnosis and to treatment outcomes, and (c) machine-learning derived early diagnostic and therapeutic options. […] We will obtain: prevalence, geographical distribution, time-to-diagnosis, number and type of referrals/visits (hospitals, AE, dentists, specialists, mental health support), diagnostic status after treatments, predictors in form of early symptoms or longitudinal patterns of misdiagnosis that can predict eventual TN diagnosis. […] The evidence obtained will support the Institute for Trigeminal Neuralgia in discussions with NHS England on establishing specialist TN care centres and pursuing early patient referral to those centres.
  • #26 Trigeminal neuralgia epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Trigeminal_neuralgia_epidemiology_and_demographics
    TN is a rare condition that affects women more than men. The annual incidence of TN is 4 to 13 per 100,000 people. […] Despite its low incidence, numbers may be significantly higher due to frequent misdiagnosis. TN is one of the more frequently seen neuralgias in the older adult population. The incidence increases gradually with age; most idiopathic cases begin after age 50, although onset may occur in the second and third decades or, rarely, in children. […] The male-to-female prevalence ratio of TN ranges from 1:1.5 to 1:1.7. This female predominance may be related to the increased longevity of women compared with men. Rare familial cases have been reported, but the vast majority of patients have sporadic disease.
  • #27 Epidemiology: Trigeminal Neuralgia — The disease is not as rare as previously thought
    https://www.prnewswire.com/news-releases/epidemiology-trigeminal-neuralgia—-the-disease-is-not-as-rare-as-previously-thought-158892165.html
    Epidemiology: Trigeminal Neuralgia The disease is not as rare as previously thought […] This module provides an estimate of the number of diagnosed incident and total prevalent cases of trigeminal neuralgia in the seven major markets using historical trends for the disease and underlying risk factors. […] Datamonitor expects to see few diagnosed incident cases of trigeminal neuralgia in all of the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK), with the majority of cases seen in the US and Germany. […] The forecast for total prevalent cases of the disease suggests the disease represents a bigger burden for the seven major markets than previously thought. […] Datamonitor epidemiologists forecast there were approximately 822,200 total prevalent cases of trigeminal neuralgia in the seven major markets in 2011.
  • #28 The Molecular Basis and Pathophysiology of Trigeminal Neuralgia
    https://www.mdpi.com/1422-0067/23/7/3604
    Trigeminal neuralgia (TN) is a complex orofacial pain syndrome characterized by the paroxysmal onset of pain attacks in the trigeminal distribution. […] The estimated incidence of TN ranges from 4.3 to 26.8 per 100,000 person-years, with a lifetime prevalence of 0.03% to 0.3%. […] Although the causes are not fully elucidated, the incidence of TN in women is higher than men, and the average age of onset is 53, with the most affected ages between 37 and 67. […] Most cases of TN are sporadic without apparent risk factors. However, there have been a few reports of familial TN, which have led to investigations of the possible genetic and molecular basis to the pathophysiology of TN.
  • #29 Interdisciplinary strategies for diagnosis and treatment of trigeminal neuralgia
    https://smw.ch/index.php/smw/article/download/3460/5981?inline=1
    Temporary, sudden, shooting and recurrent unilateral facial pain in the supply area of one or more trigeminal nerve branches characterises trigeminal neuralgia. […] The annual incidence of trigeminal neuralgia is about 4.327 per 100,000, with a lifetime prevalence of 160300 per 100,000. Women are twice as likely to be affected as men (F:M 2:1) and the average age of onset for classic trigeminal neuralgia is 53 years. […] Although some isolated cases within families imply a hereditary form of this condition, the genetic basis is still not well understood.
  • #30 Trigeminal Neuralgia Market Size,Trends and Forecast 2024-2034
    https://www.imarcgroup.com/trigeminal-neuralgia-market
    The trigeminal neuralgia market has been comprehensively analyzed in IMARC’s new report titled „Trigeminal Neuralgia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034.” […] According to the report the United States has the largest patient pool for trigeminal neuralgia and also represents the largest market for its treatment. […] IMARC Group’s new report provides an exhaustive analysis of the trigeminal neuralgia market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. […] What is the number of prevalent cases (2018-2034) of trigeminal neuralgia across the seven major markets?
  • #31 Trigeminal Neuralgia Market Size,Trends and Forecast 2024-2034
    https://www.imarcgroup.com/trigeminal-neuralgia-market
    What is the size of the trigeminal neuralgia patient pool (2018-2023) across the seven major markets? […] What would be the forecasted patient pool (2024-2034) across the seven major markets? […] What are the key factors driving the epidemiological trend of trigeminal neuralgia? […] What will be the growth rate of patients across the seven major markets?
  • #32 Trigeminal neuralgia: therapeutic strategies to restore quality of life
    https://www.jofph.com/articles/10.22514/jofph.2024.024
    Trigeminal neuralgia (TN) usually affects the maxillary and mandibular branches of the fifth cranial nerve. […] TN is uncommon however, it significantly affects patients quality of life because the neuropathic pain worsens over time. […] Although several studies focused on TN have been reported, a treatment modality with 100% efficacy is lacking. […] The first-line treatment is pharmacological however, surgery may be required if symptoms persist.
  • #33 Update on neuropathic pain treatment for trigeminal neuralgia | Neurosciences Journal
    https://nsj.org.sa/content/20/2/107
    Trigeminal neuralgia (TN) is one of the most common causes of facial pain seen in dental and neurologic practices. […] Epidemiological studies reveal a global incidence of approximately 4-28.9 per 100,000 individuals. […] Surgical interventions are reserved for patients who do not respond to adequate medical therapy. Microvascular decompression (MVD), percutaneous trigeminal rhizotomies, and gamma knife radiosurgery (GKRS) are possibly effective in the treatment of TN. […] It is estimated that up to 50% of patients with TN will require some form of surgery sooner or later.
  • #34 Burden of illness of trigeminal neuralgia among patients managed in a specialist center in England | The Journal of Headache and Pain | Full Text
    https://thejournalofheadacheandpain.biomedcentral.com/articles/10.1186/s10194-020-01198-z
    Even though most patients reported improvement since beginning treatment, the majority were still on medications, with 42% of those individuals on polytherapy. […] It is crucial that patients are aware of all available options and can change their management plans quickly depending on the status of their TN. The high numbers of current or prior medications, residual pain or complications despite surgical and/or medical interventions, and reduced QoL in those with current pain interference highlights the BOI of TN and the remaining unmet medical need.